Immune checkpoint inhibitor therapy tied to cardiac event risk
(HealthDay)—Immune checkpoint inhibitor (ICI) treatment is associated with increased cardiac events among patients with lung cancer and malignant melanoma, according to a study published online Dec. 9 in the European Heart ...
Dec 18, 2020
0
5